Celecoxib
Drug · tier A · 8 trials (2 recruiting) · 16 publications · score 76.0
Sorafenib
Drug · tier A · 8 trials (0 recruiting) · 13 publications · score 74.5
Atezolizumab
Drug · tier A · 8 trials (2 recruiting) · 13 publications · score 73.5
Erlotinib
Drug · tier A · 8 trials (0 recruiting) · 14 publications · score 72.0
Binimetinib
Drug · tier A · 8 trials (3 recruiting) · 11 publications · score 71.5
Pembrolizumab
Drug · tier A · 8 trials (3 recruiting) · 18 publications · score 70.5
Sulindac
Drug · tier A · 8 trials (0 recruiting) · 10 publications · score 69.5
Trastuzumab
Drug · tier A · 8 trials (2 recruiting) · 16 publications · score 69.5
Nivolumab
Drug · tier A · 8 trials (1 recruiting) · 18 publications · score 67.5
Vandetanib
Drug · tier A · 8 trials (0 recruiting) · 6 publications · score 61.0
Eflornithine
Drug · tier A · 7 trials (0 recruiting) · 2 publications · score 49.0
Sirolimus
Drug · tier A · 8 trials (1 recruiting) · 1 publications · score 48.5
Sirolimus
Drug · tier A · 8 trials (1 recruiting) · 1 publications · score 48.5
Enzalutamide
Drug · tier A · 8 trials (1 recruiting) · 0 publications · score 42.5
Indomethacin
Drug · tier A · 6 trials (1 recruiting) · 2 publications · score 40.5
Liothyronine
Drug · tier A · 8 trials (1 recruiting) · 0 publications · score 38.0
Vinorelbine
Drug · tier A · 3 trials (0 recruiting) · 3 publications · score 36.5
Decitabine
Drug · tier A · 5 trials (0 recruiting) · 1 publications · score 33.5
Ciprofloxacin
Drug · tier A · 4 trials (1 recruiting) · 0 publications · score 31.5
Niclosamide
Drug · tier A · 4 trials (0 recruiting) · 1 publications · score 28.0
Abiraterone Acetate
Drug · tier A · 2 trials (0 recruiting) · 0 publications · score 26.5
Trametinib Dimethyl Sulfoxide
Drug · tier A · 1 trials (0 recruiting) · 0 publications · score 24.0
Research map, not treatment advice. Built 2026-10-07.